News for ZCMD Stock

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications Zhongchao Inc. Announces 1-for-10 Share Consolidation Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment Zhongchao Inc. Announces Strategic Cooperation with Ximalaya Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction Zhongchao Inc. Renews Partnership with Johnson & Johnson (China) Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment Efficiency Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications Zhongchao Inc. Establishes Zhixun Internet Hospital to Provide Patient with Management Services Focusing on the Oncology and Other Major Diseases Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market Zhongchao Inc. Builds A Patient DOT Management System Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management Zhongchao Inc. Reports the Fiscal Year 2020 Financial Results Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKline Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts Zhongchao Inc. Reports the First Half of Fiscal Year 2020 Financial Results Zhongchao Inc. Offers Advanced Workshops in Partnership with European Wound Management Association (EWMA) Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease Zhongchao Inc. Joined Hands with Professional Non-Profit Organizations and 9 Leading Pharma Companies to Carry Out Multi-Year Online Education Project on Diagnosis and Treatment of Primary Liver Cancer Zhongchao Inc. Launches Patient Management Services Zhongchao Inc. Renews Contract with Johnson & Johnson (China) Limited, Extending the Cooperation since 2017 Zhongchao Inc. Co-organizes China-Russia-Near East Gastrointestinal Academic Dialogue